Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Autor: Hiltbrunner, S., Britschgi, C., Schuberth, P., Bankel, L., Nguyen-Kim, T.D.L., Gulati, P., Weder, W., Opitz, I., Lauk, O., Caviezel, C., Bachmann, H., Tabor, A., Schröder, P., Knuth, A., Münz, C., Stahel, R., Boyman, O., Renner, C., Petrausch, U., Curioni-Fontecedro, A.
Zdroj: In Annals of Oncology January 2021 32(1):120-121
Databáze: ScienceDirect